AUTOMATED PROTOTYPE OF CANCER DETECTION FROM CTDNA
Grant period
2023-07-01 - 2023-12-31
Funding body
European Union
Call number
HORIZON-EIE-2022-SCALEUP-02
Grant number
101114222
Identifier
G:(EU-Grant)101114222
Note: Floating Genes is a French deeptech startup incorporated in October 2021, developing early cancer detection tools from liquid biopsies. The company focuses on digestive cancers, and especially colorectal and pancreatic cancer, which is mostly detected in stage 4 and show 4.3 month of median survival. Floating Genes has developed and patented molecular biology tools to detect very rare circulating tumor DNA (ctDNA) in the blood. This will eventually allow earlier cancer diagnosis, precise monitoring and personalized treatment of patients with cancer. 200,000 lives could be saved every year in Europe with such an earlier diagnosis tool.
Recent Publications
There are no publications
Record created 2023-08-27, last modified 2023-08-27